Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1447]
News [2210]
Articles [39]
Editorials [5]
Conferences [150]
elearning [0]
Editor’s Choice for October 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for October 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
1 Nov 2018
TRITON2: Evaluation of rucaparib in patients with metastatic castration...
Dr Josep Piulats - IDIBELL, Barcelona, Spain
TRITON2: Evaluation of rucaparib in patients with metastatic castration-resistant prostate cancer ( Dr Josep Piulats - IDIBELL, Barcelona, Spain )
26 Oct 2018
ASCEND-8: safety data of ceritinib with or without food in NSCLC
Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, Republic of Korea
ASCEND-8: safety data of ceritinib with or without food in NSCLC ( Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, Republic of Korea )
26 Oct 2018
VALENTINO: Maintenance therapy in advanced CRC
Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation...
VALENTINO: Maintenance therapy in advanced CRC ( Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy )
25 Oct 2018
Ceritinib and ribociclib in ALK-positive NSCLC
Dr Enriqueta Felip - Vall d'Hebron Institute of Oncology (VHIO), Barcelona...
Ceritinib and ribociclib in ALK-positive NSCLC ( Dr Enriqueta Felip - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
24 Oct 2018
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy
Dr Linda M. Henricks - Netherlands Cancer Institute, Amsterdam, Netherlands
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy ( Dr Linda M. Henricks - Netherlands Cancer Institute, Amsterdam, Netherlands )
24 Oct 2018
Comment on the Every Woman Study
Clara MacKay - World Ovarian Cancer Coalition, Canada
Comment on the Every Woman Study ( Clara MacKay - World Ovarian Cancer Coalition, Canada )
24 Oct 2018
Combining MRD quantitation and genetics in post-remission risk stratification
Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Combining MRD quantitation and genetics in post-remission risk stratification ( Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
18 Oct 2018
Editor’s Choice for September 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for September 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
28 Sep 2018
Implementing psychotherapy as part of healthcare services in Lebanon
Dr Kai Ruggeri - University of Cambridge, Cambridge, UK, Tomas Folke...
Implementing psychotherapy as part of healthcare services in Lebanon ( Dr Kai Ruggeri - University of Cambridge, Cambridge, UK, Tomas Folke, University of Cambridge, Cambridge, UK )
18 Sep 2018
Palliative care in areas of conflict
Dr Omar Shamieh - King Hussein Cancer Centre, Amman, Jordan, Prof Richard...
Palliative care in areas of conflict ( Dr Omar Shamieh - King Hussein Cancer Centre, Amman, Jordan, Prof Richard Harding - Centre for Global Health Palliative Care, London, UK )
18 Sep 2018
Research for health in conflict - preserving life and wellbeing in populations...
Dr Preeti Patel - King's College London, London, Prof Richard Sullivan - King's...
Research for health in conflict - preserving life and wellbeing in populations affected by violence ( Dr Preeti Patel - King's College London, London, Prof Richard Sullivan - King's College London, London )
18 Sep 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation